“showed a trend”

Jejunal MUC-2 expressions ( Figure 6 ) showed a trend of increase ( p > 0.05) in GTE treatments compared to the controls (with and without challenge).

With the addition of CSN, the WS value of the pH-responsive film showed a trend of decreasing ( p < 0.05).

Of these genes, 11 showed a trend for differential expression between KdVS and controls ( p -value < 0.05; C5orf49, CLCN4 , DMD , RBBP7, TBX2, USP9X, FAM78B, TIMP2, TLE4, ZNF717 and TIGD5 ; Fig.

Higher TTP at baseline, an indication of lower baseline disease burden, showed a trend to lower incidence of unfavorable outcomes ( P = .05).

In addition, capsule wall thickness showed a trend to increase with time after implantation in the Resilon groups ( P < 0.05), opposed to the significant decrease ( P = 0.016) observed after implantation in the gutta-percha groups, suggesting lesser long-term biocompatibility of Resilon.

Subgroup analyses comparing starting versus relief pitchers with UCL injuries showed a trend toward faster pitch timer durations in starting pitchers; however, these findings were ultimately underpowered ( P > .05) ( Table 5 ).

End-effector robots (n = 6) showed significant improvement (SMD = 0.30, 95% CI: 0.03–0.58, p = 0.030, I 2 = 0%), while exoskeletons showed a trend (SMD = 0.72, 95% CI: −0.01 to 1.45, p = 0.050, I 2 = 78%) ( Figure 3 B). 3.4.3.

The other regions showed a trend towards indicator stability (p > 0.05).

Both NPs + Probiotics 10 9 CFU and NPs + Probiotics 10 10 CFU groups showed a trend toward reduced MDA levels compared to NPs alone (p < 0.05).

Additionally, the TC, TG, LDL-C and HDL-C concentrations in the ε4 carrier control participants showed a trend towards higher levels compared to the DN group (all p > 0.05).

WT + Trp and HET + Trp mice showed a trend toward a decrease in the relative content of adipose tissue (22.4% and 5.9%, p > 0.05) and an increase in muscle tissue throughout the study (5.9% and 2.9%, p > 0.05).

Although the mean median pitch remained within normal range with an overall non-significant change (−3.8, NS), analysis by gender showed a trend for statistical significance ( P = 0.05) on the impact on median pitch (i.e. the fundamental frequency): while it decreased among 80% of the female patients [from 203 ± 38 to 189 ± 31 Hz (normal range: 140–220 Hz), n = 19], it was almost unchanged in the male patients [from 135.2 ± 23 to 134.5 ± 26 Hz (normal range: 85–180 Hz), n = 29] ( Supplementary Fig. 1 ).

Regarding fibrosis indicators, although PCSK9i use showed a trend toward improvement in Δ APRI (β = −0.021) and Δ FIB-4 (β = −0.19), these associations did not reach statistical significance in the adjusted model ( P > 0.05).

Conversely, PD/CCs showed a trend to decrease (P>0.05) in CLDN4 and OCCL-1 protein levels than controls, whereas ZO-1 protein was comparable.

The 500 nm particles significantly decreased cell viability in the astrocytes by ~85% at 1000 μg/mL and showed a trend of ~30% decrease at 100 μg/mL ( Figure 2 B, p -value < 0.05).

More exposure to cytotoxic chemotherapy before osimertinib showed a trend toward systemic PD (20.0% vs. 37.9%, p = 0.05, Table 2 ).

These benefits persisted during follow-up: headache days (standardized mean difference [SMD], −0.70; P <0.00001), intensity (SMD, −1.11; P =0.008), duration (SMD, −1.83; P =0.003), and analgesic use (SMD, −0.60; P =0.007) remained reduced; headache frequency showed a trend toward reduction (SMD, −0.47; P =0.05).

The area of fully transmural infarction showed a trend towards significant resolution of strain with time (means -0.103 (day 2), -0.148 (day 30) and -0.194 (day 90); P=0.050 for trend).

The C3 −/− mice showed a trend towards higher numbers of phospho-histone H3-positive (PHH3 + ) cells, i.e. cells proliferating at the time of sacrifice, in the GCL after IR (Figure 3C-3D , P = 0.0500).

The genus Butyricicoccus showed a trend toward lower abundance in the Control group but did not reach statistical significance after FDR correction ( P < 0.05, q -value = 0.055) ( Figure 4B ).

At the beginning of the trial, males showed a trend toward choosing the EO-treated arm, although no statistical differences were found (χ 2 = 2.46; p > 0.05), whereas females showed a preference for the EO-treated arm (χ 2 = 4.17; p = 0.04) ( Table 2 ), but no significant differences were observed at the end of the trial (χ 2 =3.11; p > 0.05).

Although perforin showed a trend toward downregulation (p > 0.05), the difference was not statistically significant during Mtb infection ( Figures 5A–D ).

The group effect for the P3b amplitude showed a trend toward significance ( F (1,38) = 4.081, p = 0.050), although the result did not reach the conventional threshold for statistical significance ( p < 0.05; Table 4 , Figure 5 ).

The pooled analysis using a random-effects model showed a trend toward improvement with BFR but failed to reach statistical significance (SMD = 0.97; 95% CI [− 0.00, 1.95]; P = 0.05) (Fig. 7 ).

Although there was no statistically significant difference in postoperative hospitalization between the 2 groups, the mEMR-C group showed a trend toward reducing postoperative length of stay compared with the ESD group (without adjustment: P < 0.05; with adjustment: P = 0.075).